[go: up one dir, main page]

NO914306L - Fremgangsmaate for forbedring av fruktbarhet - Google Patents

Fremgangsmaate for forbedring av fruktbarhet

Info

Publication number
NO914306L
NO914306L NO91914306A NO914306A NO914306L NO 914306 L NO914306 L NO 914306L NO 91914306 A NO91914306 A NO 91914306A NO 914306 A NO914306 A NO 914306A NO 914306 L NO914306 L NO 914306L
Authority
NO
Norway
Prior art keywords
paf
pct
antagonist
homologue
uterus
Prior art date
Application number
NO91914306A
Other languages
English (en)
Other versions
NO914306D0 (no
NO179125B (no
NO179125C (no
Inventor
Christopher O'neill
Original Assignee
North Sydney Area Health Serv
Oneill Christopher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Sydney Area Health Serv, Oneill Christopher filed Critical North Sydney Area Health Serv
Publication of NO914306D0 publication Critical patent/NO914306D0/no
Publication of NO914306L publication Critical patent/NO914306L/no
Publication of NO179125B publication Critical patent/NO179125B/no
Publication of NO179125C publication Critical patent/NO179125C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Retarders (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO914306A 1989-05-05 1991-11-01 Preparat for forbedring av implantasjon av et embryo i uterus hos et hunnpattedyr NO179125C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ405489 1989-05-05
PCT/AU1990/000183 WO1990013299A1 (en) 1989-05-05 1990-05-07 Fertility enhancement

Publications (4)

Publication Number Publication Date
NO914306D0 NO914306D0 (no) 1991-11-01
NO914306L true NO914306L (no) 1992-01-03
NO179125B NO179125B (no) 1996-05-06
NO179125C NO179125C (no) 1996-08-14

Family

ID=3773897

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914306A NO179125C (no) 1989-05-05 1991-11-01 Preparat for forbedring av implantasjon av et embryo i uterus hos et hunnpattedyr

Country Status (9)

Country Link
US (1) US5240922A (no)
EP (1) EP0473612B1 (no)
KR (1) KR920700648A (no)
AT (1) ATE140868T1 (no)
CA (1) CA2054197A1 (no)
DE (1) DE69027992D1 (no)
HU (1) HUT60631A (no)
NO (1) NO179125C (no)
WO (1) WO1990013299A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540766A1 (en) * 1991-11-04 1993-05-12 Korth, Ruth-Maria, Dr. med Treatment of eosinophil-mediated diseases with Paf antagonists and procedure for determining their efficacy.
US5895785A (en) * 1987-10-20 1999-04-20 Ruth Korth Treatment and prevention of disorders mediated by LA-paf or endothelial cells
DE540767T1 (de) * 1991-11-04 2001-10-25 Ruth-Maria Korth Behandlung und Vorbeugung von von erhöhten Lyso-PAF-Spiegel mediierten mentalen Erkrankungen mit PAF-Antagonisten
GB9227123D0 (en) * 1992-12-30 1993-02-24 Applied Research Systems Method
US5599918A (en) * 1994-10-04 1997-02-04 La Jolla Cancer Research Foundation Nucleic acids encoding trophinin and trophinin-assisting proteins
US5654145A (en) * 1994-10-04 1997-08-05 La Jolla Cancer Research Foundation Trophinin and trophinin-assisting nucleic acids and methods of detection thereof
US6022563A (en) * 1998-02-04 2000-02-08 Superior Equine Pharmaceuticals, Inc. Phenylbutazone carrier formulation
WO2002085180A2 (en) * 2001-04-18 2002-10-31 Family Health International Vasectomy procedure and related kit
CA2447519C (en) 2001-05-24 2008-09-16 Alexza Molecular Delivery Corporation Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
DE602004030546D1 (de) * 2003-03-04 2011-01-27 Aspenbio Pharma Inc LH zur Verwendung der Erhaltung einer oder mehreren Schwangerschaften durch Induktion der Bildung des sekundären Gelbkörpers.
JP2007516404A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ， インコーポレイテッド 光学点火されたかまたは電気点火された内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
CA2536112A1 (en) * 2003-08-20 2005-03-03 Northern Sydney And Central Coast Area Health Service Methods for enhancing embryo viability
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (en) 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heating unit
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
US20110021591A1 (en) * 2009-07-21 2011-01-27 Gordon Douglas J Phenylbutazone carrier formulation showing increased bioactivity in animals
WO2012008467A1 (ja) 2010-07-12 2012-01-19 株式会社エリナ axial-equatorial aryl配向のfurofuran型リグナンを含有する骨形成促進用医薬組成物、その組成物を含有する医薬製剤、その組成物を含む機能性食品及び健康食品
PL3569697T3 (pl) 2014-06-17 2022-07-04 Asherman Therapy, S.L. Terapia komórkami macierzystymi w patologiach endometrium
KR102852740B1 (ko) 2018-02-02 2025-08-29 알렉스자 파마스티칼즈, 인크. 전기적 응축 에어로졸 디바이스

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973603A (en) * 1988-06-16 1990-11-27 Sumner Burstein Platelet activating factor antagonist and methods of use therefor

Also Published As

Publication number Publication date
HUT60631A (en) 1992-10-28
EP0473612A1 (en) 1992-03-11
WO1990013299A1 (en) 1990-11-15
NO914306D0 (no) 1991-11-01
ATE140868T1 (de) 1996-08-15
EP0473612A4 (en) 1992-11-19
EP0473612B1 (en) 1996-07-31
NO179125B (no) 1996-05-06
NO179125C (no) 1996-08-14
HU9004445D0 (en) 1992-02-28
US5240922A (en) 1993-08-31
KR920700648A (ko) 1992-08-10
CA2054197A1 (en) 1990-11-06
DE69027992D1 (de) 1996-09-05

Similar Documents

Publication Publication Date Title
NO914306D0 (no) Fremgangsmaate for forbedring av fruktbarhet
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
GR3019315T3 (en) Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
DE69017302D1 (de) Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten.
BR9406823A (pt) Aminas secundárias e agentes anti-diabéticos e antiobesidade
MX9203667A (es) Sales de bis-dimetoximetil (trimetoxibencil)quinolino, su preparacion y composicines farmaceuticas que las contienen.
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
PT74928B (en) New anti-thromboticum based on polysachatides method for its preparation and pharmaceutical compositions
DE69432929D1 (de) Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
ATE150301T1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
ES2134768T3 (es) Composicion farmaceutica que comprende un fosfoazucar.
DE3468682D1 (en) Amidines, process for their preparation and their therapeutical use
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
MD940152A (ro) Compoziţie farmaceutică pentru tratarea infecţiilor şi bolilor, provocate de virusul hepatitei V (HBV)
SE8903529D0 (sv) Medical use
DK527186A (da) Bronchodilaterende farmaceutisk praeparat
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
SE9403160D0 (sv) Method and means for prevention and treatment of secondary cataract
ATE128871T1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
ATE153859T1 (de) Somatotropin zur erhoehung der reproduktiven leistung in rinder
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
SE9001592L (sv) Terapeutisk komposition
TNSN94110A1 (fr) Procede de preparation de compositions orales contenant des quinolones